Skip to main content

NGM Biopharmaceuticals Inc

NGMDelisted Apr 5, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001426332

NGM Biopharmaceuticals Inc was delisted on Apr 5, 2024; its insiders filed their last Form 4 on Apr 8, 2024; 75 institutions reported holding it in 13F filings for Q1 2024, worth $55.1M in total; no superinvestor held it.

13F holders, Q2 2022

Institutional positions in NGM Biopharmaceuticals Inc as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
124
+12 vs. Q1 2022
Shares held
47.3M
−701.1K (−1.5%) vs. Q1 2022
Total value
$607.3M
−$125.2M (−17.1%) vs. Q1 2022
New holders
26
50 more added
Sold out
14
28 more reduced

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting NGM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 124 institutions
Q1 2021: 108 institutionsQ2 2021: 107 institutionsQ3 2021: 121 institutionsQ4 2021: 119 institutionsQ1 2022: 114 institutionsQ2 2022: 124 institutionsQ3 2022: 128 institutionsQ4 2022: 125 institutionsQ1 2023: 123 institutionsQ2 2023: 106 institutionsQ3 2023: 95 institutionsQ4 2023: 83 institutionsQ1 2024: 75 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2022: $607.3M
Q1 2021: $1.25BQ2 2021: $849.7MQ3 2021: $951.2MQ4 2021: $833.5MQ1 2022: $732.8MQ2 2022: $607.3MQ3 2022: $689.9MQ4 2022: $248.9MQ1 2023: $200.4MQ2 2023: $124.4MQ3 2023: $50.6MQ4 2023: $35.3MQ1 2024: $55.1MQ2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding NGM and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 202475$55.1M
Q4 202383$35.3M
Q3 202395$50.6M
Q2 2023106$124.4M
Q1 2023123$200.4M
Q4 2022125$248.9M
Q3 2022128$689.9M
Q2 2022124$607.3M
Q1 2022114$732.8M
Q4 2021119$833.5M
Q3 2021121$951.2M
Q2 2021107$849.7M
Q1 2021108$1.25B

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding NGM Biopharmaceuticals Inc; share changes are against Q1 2022.

Institutions holding NGM in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Jasper Ridge Partners, L.P.318,750$4.09M0.25%+7,500+2.4%Added
Renaissance Technologies LLC338,368$4.34M0.01%+182,668+117.3%Added
Northern Trust Corp341,251$4.38M0.00%+48,145+16.4%Added
AXA S.A.402,443$5.16M0.02%−7,825−1.9%Reduced
Millennium Management LLC441,475$5.66M0.01%+24,059+5.8%Added
Boxer Capital, LLC500,000$6.41M0.41%00.0%Unchanged
Nuveen Asset Management, LLC535,438$6.86M0.00%+288,412+116.8%Added
EcoR1 Capital, LLC541,108$6.94M0.24%00.0%Unchanged
JPMorgan Chase & Co552,541$7.08M0.00%+18,620+3.5%Added
Morgan Stanley591,224$7.58M0.00%+10,520+1.8%Added
Dimensional Fund Advisors LP646,718$8.29M0.00%+87,379+15.6%Added
Geode Capital Management, LLC728,614$9.34M0.00%+26,300+3.7%Added
Euclidean Capital LLC746,674$9.57M8.14%00.0%Unchanged
State Street Corp770,442$9.88M0.00%+78,936+11.4%Added
Rubric Capital Management LP797,588$10.2M0.54%+797,588New
First Light Asset Management, LLC1,135,884$14.6M1.69%+319,231+39.1%Added
Ponoi Management, LLC1,298,908$16.7M26.29%00.0%Unchanged
Ponoi II Management, LLC1,298,908$16.7M45.25%00.0%Unchanged
Point72 Asset Management, L.P.1,320,662$16.9M0.08%−1,890,209−58.9%Reduced
StepStone Group LP1,573,357$20.2M2.16%00.0%Unchanged
FMR LLC2,060,533$26.4M0.00%+787,347+61.8%Added
Vanguard Group Inc3,403,208$43.6M0.00%+388,733+12.9%Added
BlackRock Inc.3,872,749$49.6M0.00%+1,033,075+36.4%Added
The Column Group LLC18,136,735$232.5M49.49%+1,890,918+11.6%Added
Rho Capital Partners Inc0$00.00%−3,766,666−100.0%Sold out
BVF Inc0$00.00%−955,000−100.0%Sold out
Jacobs Levy Equity Management, Inc0$00.00%−351,943−100.0%Sold out
Norges Bank0$00.00%−95,400−100.0%Sold out
Allianz Asset Management GmbH0$00.00%−48,070−100.0%Sold out
HighVista Strategies LLC0$00.00%−46,243−100.0%Sold out
Squarepoint Ops LLC0$00.00%−38,747−100.0%Sold out
PDT Partners, LLC0$00.00%−38,179−100.0%Sold out
Trexquant Investment LP0$00.00%−25,147−100.0%Sold out
Public Employees Retirement System of Ohio0$00.00%−18,277−100.0%Sold out
Point72 Hong Kong Ltd0$00.00%−2,034−100.0%Sold out
Princeton Global Asset Management LLC0$00.00%−1,600−100.0%Sold out
Bedel Financial Consulting, Inc.0$00.00%−100−100.0%Sold out
Allworth Financial LP0$00.00%−13−100.0%Sold out
Parametric Portfolio Associates LLC––––Not filed
Amalgamated Financial Corp.––––Not filed